表紙:血行動態モニタリングデバイスの世界市場 (2021-2030年):製品・モダリティ・施設・地域別
市場調査レポート
商品コード
1008357

血行動態モニタリングデバイスの世界市場 (2021-2030年):製品・モダリティ・施設・地域別

Global Hemodynamic Monitoring Devices Market: Focus on Product, Modality, Setting, and 21 Countries - Analysis and Forecast, 2021-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 263 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
血行動態モニタリングデバイスの世界市場 (2021-2030年):製品・モダリティ・施設・地域別
出版日: 2021年05月19日
発行: BIS Research Inc.
ページ情報: 英文 263 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血行動態モニタリングデバイスの市場規模は2030年には21億5660万米ドルの規模に成長すると予測されています。

当レポートでは、世界の血行動態モニタリングデバイスの市場を調査し、市場の定義と概要、バリューチェーン、疫学的動向、規制の枠組み、特許分析、製品ベンチマーキング、臨床試験の動向、市場影響因子の分析、市場規模の推移・予測、製品・モダリティ・施設・地域など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 COVID-19の影響

第5章 産業分析

  • 疫学分析・予測
  • 技術情勢
  • バリューチェーン分析
  • エンドユーザーの認識
  • 資金調達シナリオ
  • 規制の枠組み・政府の取り組み
  • 特許分析
  • 製品のベンチマーキング
  • 進行中の臨床試験

第6章 競合情勢

  • 市場シェア分析
  • 主な戦略・展開
  • ビジネスモデルの分析
  • 主要企業の競合ベンチマーキング

第7章 市場成長シナリオ

  • 前提条件・制約
  • 主要調査結果・機会の分析
  • 市場規模・予測:シナリオ別
  • 市場力学
    • 影響分析
    • 成長促進要因
    • 成長抑制要因
    • 成長機会

第8章 市場分析・予測:製品別

  • カテーテル
  • センサー
  • 監視システム
  • その他(プローブ、ポッドなど)

第9章 市場分析・予測:モダリティ別

  • 侵襲的
  • 最小侵襲的
  • 非侵襲的

第10章 市場分析・予測:施設別

  • 病院
  • クリニック
  • 外来ユニット
  • 在宅ケア
  • その他(養護施設・老人ホーム等)

第11章 市場分析・予測:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 企業プロファイル

  • 既存企業
  • 新興企業の概要
図表

List of Tables

  • Table 1: Global Hemodynamic Monitoring Devices Market, Quarterly Regional Impact, 2020
  • Table 2: Global Hemodynamic Monitoring Devices Market, Key Technology Trends
  • Table 4.1: Global Hemodynamic Monitoring Devices Market, Quarterly Regional Impact, 2020
  • Table 5.1: Global Hemodynamic Monitoring Devices Market Funding Scenario, 2017-2021
  • Table 5.2: European Commission Medical Device Directives
  • Table 5.3: Global Hemodynamic Monitoring Devices Market: Awaited Technologies
  • Table 5.4: Global Hemodynamic Monitoring Devices Market Patent Analysis (by Country), 1985-2021
  • Table 5.5: Global Hemodynamic Monitoring Devices Product Benchmarking Analysis (by Product Type)
  • Table 5.6: Global Hemodynamic Monitoring Devices Market Ongoing Clinical Trials
  • Table 6.1: Global Hemodynamic Monitoring Devices Market, Business Model Analysis
  • Table 11.1: Prevalence of Cardiovascular Diseases and Diabetes in North America, 2000, 2010, 2018, and 2019
  • Table 11.2: North America Hemodynamic Monitoring Devices Market, Impact Analysis
  • Table 11.3: Prevalence of Cardiovascular Diseases and Diabetes in Europe, 2000, 2010, 2018, and 2019
  • Table 11.4: Europe Hemodynamic Monitoring Devices Market, Impact Analysis
  • Table 11.5: Prevalence of Cardiovascular Diseases and Diabetes in Asia-Pacific, 2000, 2010, 2018, and 2019
  • Table 11.6: Asia-Pacific Hemodynamic Monitoring Devices Market, Impact Analysis
  • Table 11.7: Prevalence of Cardiovascular Diseases and Diabetes in Latin America, 2000, 2010, 2018, and 2019
  • Table 11.8: Latin America Hemodynamic Monitoring Devices Market, Impact Analysis
  • Table 11.9: Prevalence of Cardiovascular Diseases and Diabetes in Middle East and Africa, 2000, 2010, 2018, and 2019
  • Table 11.10: Middle East and Africa Hemodynamic Monitoring Devices Market, Impact Analysis

List of Figures

  • Figure 1: Global Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 2: Global Hemodynamic Monitoring Devices Market, Impact Analysis
  • Figure 3: Global Hemodynamic Monitoring Devices Market Share Analysis (by Company), 2018-2020
  • Figure 4: Global Hemodynamic Monitoring Devices Market (by Setting), 2018 and 2030
  • Figure 5: Global Hemodynamic Monitoring Devices Market (by Region), 2018 and 2030
  • Figure 2.1: Global Hemodynamic Monitoring Devices Market Segmentation
  • Figure 2.2: Global Hemodynamic Monitoring Devices Market, Regional Segmentation
  • Figure 3.1: Global Hemodynamic Monitoring Devices Market: Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Assumptions and Limitations
  • Figure 4.1: Global Hemodynamic Monitoring Devices Market, Scenario Comparative Analysis
  • Figure 5.1: Global Prevalence (Cardiovascular Diseases), 2000-2030
  • Figure 5.2: Global Prevalence (Diabetes Mellitus), 2000-2030
  • Figure 5.3: Global Hemodynamic Monitoring Devices Market: Key Technology Trends
  • Figure 5.4: Global Hemodynamic Monitoring Devices Market Key Trends Short-Term Potential (by Region)
  • Figure 5.5: Global Hemodynamic Monitoring Devices Market Key Trends Mid-Term Potential (by Region)
  • Figure 5.6: Global Hemodynamic Monitoring Devices Market Key Trends Long-Term Potential (by Region)
  • Figure 5.7: Global Hemodynamic Monitoring Devices Market Value Chain Analysis
  • Figure 5.8: Global Hemodynamic Monitoring Devices End User Perceptions
  • Figure 5.9: FDA Regulatory Pathway for Medical Devices
  • Figure 5.10: Health Canada Regulatory Pathway for Device
  • Figure 5.11: MDR Transitional Provisions (EU)
  • Figure 5.12: PMDA Regulatory Pathway for Medical Devices
  • Figure 5.13: NMPA Regulatory Pathway for Medical Device
  • Figure 6.1: Global Hemodynamic Monitoring Devices Market, Share Analysis, (by Company), 2020
  • Figure 6.2: Global Hemodynamic Monitoring Devices Market, Share of Key Developments and Strategies, January 2016-March 2021
  • Figure 6.3: Global Hemodynamic Monitoring Devices Market, Regulatory and Legal (by Company), January 2016- March 2021
  • Figure 6.4: Global Hemodynamic Monitoring Devices Market, Funding Activities (by Company), January 2016- March 2021
  • Figure 6.5: Global Hemodynamic Monitoring Devices Market, M&A Activities (by Company), January 2016- March 2021
  • Figure 6.6: Global Hemodynamic Monitoring Devices Market, Partnerships, Collaborations, and Business Expansions (by Company), January 2016- March 2021
  • Figure 6.7: Global Hemodynamic Monitoring Devices Market, Competitive Benchmarking (by Company)
  • Figure 7.1: Global Hemodynamic Monitoring Devices Market, Realistic Scenario, $Million, 2018-2030
  • Figure 7.2: Global Hemodynamic Monitoring Devices Market, Pessimistic/ Conservative Growth Scenario, $Million, 2018-2030
  • Figure 7.3: Global Hemodynamic Monitoring Devices Market, Optimistic Scenario, $Million, 2019-2030
  • Figure 7.4: Global Hemodynamic Monitoring Devices Market, Impact Analysis
  • Figure 7.5: Rising Prevalence of Cardiac Disorders, 2010-2019
  • Figure 8.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Product), $Million, 2018 and 2030
  • Figure 8.2: Global Hemodynamic Monitoring Devices Market (by Catheters), $Million, 2018-2030
  • Figure 8.3: Global Hemodynamic Monitoring Devices Market (by Sensors), $Million, 2018-2030
  • Figure 8.4: Global Hemodynamic Monitoring Devices Market (by Monitoring System), $Million, 2018-2030
  • Figure 8.5: Global Hemodynamic Monitoring Devices Market (by Others), $Million, 2018-2030
  • Figure 9.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Modality), $Million, 2018 and 2030
  • Figure 9.2: Global Hemodynamic Monitoring Devices Market (by Invasive), $Million, 2018-2030
  • Figure 9.3: Global Hemodynamic Monitoring Devices Market (by Minimally Invasive), $Million, 2018-2030
  • Figure 9.4: Global Hemodynamic Monitoring Devices Market (by Non-Invasive), $Million, 2018-2030
  • Figure 10.1: Global Hemodynamic Monitoring Devices Market Increment Opportunity (by Setting), $Million, 2018 and 2030
  • Figure 10.2: Global Hemodynamic Monitoring Devices Market (by Hospitals), $Million, 2018-2030
  • Figure 10.3: Global Hemodynamic Monitoring Devices Market (by Clinics), $Million, 2018-2030
  • Figure 10.4: Global Hemodynamic Monitoring Devices Market (by Ambulatory Units), $Million, 2018-2030
  • Figure 10.5: Global Hemodynamic Monitoring Devices Market (by Homecare), $Million, 2018-2030
  • Figure 10.6: Global Hemodynamic Monitoring Devices Market (by Others), $Million, 2018-2030
  • Figure 11.1: Global Hemodynamic Monitoring Devices Market (by Geography), 2018 and 2030
  • Figure 11.2: Global Hemodynamic Monitoring Devices Market, Increment Opportunity (by Region), $Million, 2018 and 2030
  • Figure 11.3: North America Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030
  • Figure 11.4: North America Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.5: North America Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030
  • Figure 11.6: North America Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030
  • Figure 11.7: North America Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030
  • Figure 11.8: North America Hemodynamic Monitoring Devices Market (by Country)
  • Figure 11.9: U.S. Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.10: Canada Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.11: Europe Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030
  • Figure 11.12: Europe Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.13: Europe Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030
  • Figure 11.14: Europe Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030
  • Figure 11.15: Europe Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030
  • Figure 11.16: Europe Hemodynamic Monitoring Devices Market (by Country)
  • Figure 11.17: Germany Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.18: U.K. Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.19: France Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.20: Italy Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.21: Spain Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.22: Nordic Countries Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.23: Rest-of-Europe Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.24: Asia-Pacific Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030
  • Figure 11.25: Asia-Pacific Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.26: Asia-Pacific Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030
  • Figure 11.27: Asia-Pacific Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030
  • Figure 11.28: Asia-Pacific Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030
  • Figure 11.29: Asia-Pacific Hemodynamic Monitoring Devices Market (by Country)
  • Figure 11.30: Japan Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.31: China Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.32: South Korea Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.33: Australia and New Zealand Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.34: India Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.35: Singapore Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.36: Rest-of-Asia-Pacific Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.37: Latin America Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030
  • Figure 11.38: Latin America Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.39: Latin America Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030
  • Figure 11.40: Latin America Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030
  • Figure 11.41: Latin America Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030
  • Figure 11.42: Latin America Hemodynamic Monitoring Devices Market (by Country)
  • Figure 11.43: Brazil Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.44: Mexico Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.45: Argentina Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.46: Colombia Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.47: Rest-of-Latin America Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.48: Middle East and Africa Hemodynamic Monitoring Devices Market, Incremental Growth Opportunity, $Million, 2018 and 2030
  • Figure 11.49: Middle East and Africa Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.50: Middle East and Africa Hemodynamic Monitoring Devices Market (by Product), $Million, 2018-2030
  • Figure 11.51: Middle East and Africa Hemodynamic Monitoring Devices Market (by Modality), $Million, 2018-2030
  • Figure 11.52: Middle East and Africa Hemodynamic Monitoring Devices Market (by Setting), $Million, 2018-2030
  • Figure 11.53: Middle East and Africa Hemodynamic Monitoring Devices Market (by Country)
  • Figure 11.54: K.S.A. Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.55: Israel Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.56: South Africa Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 11.57: Rest-of-MEA Hemodynamic Monitoring Devices Market, $Million, 2018-2030
  • Figure 12.1: Shares of Key Companies Profiled
  • Figure 12.2: Baxter International Inc.: Overall Product Portfolio
  • Figure 12.3: Baxter International Inc.: Overall Financials, 2018-2020
  • Figure 12.4: Baxter International Inc. Revenue (by Business Unit), 2018-2020
  • Figure 12.5: Baxter International Inc. Revenue (by Region), 2018-2020
  • Figure 12.6: Baxter International Inc. R&D Expenditure 2018-2020
  • Figure 12.7: SWOT Analysis: Baxter International Inc.
  • Figure 12.8: Caretaker, LLC: Overall Product Portfolio
  • Figure 12.9: SWOT Analysis: Caretaker, LLC
  • Figure 12.10: CN Systems Medizintechnik GmbH: Overall Product Portfolio
  • Figure 12.11: SWOT Analysis: CN Systems Medizintechnik GmbH
  • Figure 12.12: Deltex Medical Group PLC: Overall Product Portfolio
  • Figure 12.13: Deltex Medical Group PLC.: Overall Financials, 2017-2019
  • Figure 12.14: Deltex Medical Group PLC Revenue (by Segment), 2017-2019
  • Figure 12.15: Deltex Medical Group PLC Revenue (by Region), 2017-2019
  • Figure 12.16: Deltex Medical Group PLC R&D Expenditure 2017-2019
  • Figure 12.17: SWOT Analysis: Deltex Medical Group PLC
  • Figure 12.18: Dragerwerk AG & Co. KGaA: Overall Product Portfolio
  • Figure 12.19: Dragerwerk AG & Co. KGaA: Overall Financials, 2018-2020
  • Figure 12.20: Dragerwerk AG & Co. KGaA Revenue (by Region), 2017-2019
  • Figure 12.21: Dragerwerk AG & Co. KGaA Revenue (by Business Segment), 2020
  • Figure 12.22: Dragerwerk AG & Co. KGaA R&D Expenditure 2018-2020
  • Figure 12.23: SWOT Analysis: Dragerwerk AG & Co. KGaA
  • Figure 12.24: Edwards Lifesciences Corporation.: Overall Product Portfolio
  • Figure 12.25: Edwards Lifesciences Corporation.: Overall Financials, 2018-2020
  • Figure 12.26: Edwards Lifesciences Corporation. Revenue (by Business Segment), 2018-2020
  • Figure 12.27: Edwards Lifesciences Corporation. Revenue (by Region), 2018-2020
  • Figure 12.28: Edwards Lifesciences Corporation. R&D Expenditure 2018-2020
  • Figure 12.29: SWOT Analysis: Edwards Lifesciences Corporation.
  • Figure 12.30: GENERAL ELECTRIC COMPANY.: Overall Product Portfolio
  • Figure 12.31: GENERAL ELECTRIC COMPANY.: Overall Financials, 2018-2020
  • Figure 12.32: GENERAL ELECTRIC COMPANY Revenue (by Business Segment), 2018-2020
  • Figure 12.33: GENERAL ELECTRIC COMPANY Revenue (by Region), 2018-2020
  • Figure 12.34: GENERAL ELECTRIC COMPANY, R&D Expenditure 2018-2020
  • Figure 12.35: GENERAL ELECTRIC COMPANY, R&D Expenditure Comparison, 2018-2020
  • Figure 12.36: SWOT Analysis: GENERAL ELECTRIC COMPANY
  • Figure 12.37: Getinge AB: Overall Product Portfolio
  • Figure 12.38: Getinge AB: Overall Financials, 2018-2020
  • Figure 12.39: Getinge AB Revenue (by Business Segment), 2018-2020
  • Figure 12.40: Getinge AB Revenue (by Region), 2018-2020
  • Figure 12.41: Getinge AB R&D Expenditure 2018-2020
  • Figure 12.42: SWOT Analysis: Getinge AB
  • Figure 12.43: ICU MEDICAL, INC. Overall Product Portfolio
  • Figure 12.44: ICU MEDICAL, INC..: Overall Financials, 2017-2019
  • Figure 12.45: ICU MEDICAL, INC. Revenue (by Business Unit), 2018-2020
  • Figure 12.46: ICU MEDICAL, INC. Revenue (by Region), 2018-2020
  • Figure 12.47: ICU MEDICAL, INC. R&D Expenditure 2017-2019
  • Figure 12.48: SWOT Analysis: ICU MEDICAL, INC.
  • Figure 12.49: Koninklijke Philip N.V.: Overall Product Portfolio
  • Figure 12.50: Koninklijke Philips N.V.: Overall Financials, 2018-2020
  • Figure 12.51: Koninklijke Philips N.V. Revenue (by Business Segment), 2018-2020
  • Figure 12.52: Koninklijke Philips N.V. Revenue (by Region), 2018-2020
  • Figure 12.53: Koninklijke Philips N.V. R&D Expenditure 2018-2020
  • Figure 12.54: SWOT Analysis: Koninklijke Philips N.V.
  • Figure 12.55: Masimo Corporation: Overall Product Portfolio
  • Figure 12.56: LiDCO Group PLC.: Overall Financials, 2018-2020
  • Figure 12.57: LiDCO Group PLC Revenue (by Region), 2018-2020
  • Figure 12.58: LiDCO Group PLC R&D Expenditure 2018-2020
  • Figure 12.59: SWOT Analysis: Masimo Corporation (Parent Company of LiDCO Group PLC)
  • Figure 12.60: NI Medical Ltd.: Overall Product Portfolio
  • Figure 12.61: SWOT Analysis: NI Medical Ltd.
  • Figure 12.62: Osypka Medical GmbH: Overall Product Portfolio
  • Figure 12.63: SWOT Analysis: Osypka Medical GmbH
  • Figure 12.64: Schwarzer Cardiotek: Overall Product Portfolio
  • Figure 12.65: SWOT Analysis: Schwarzer Cardiotek
  • Figure 12.66: Sramek BioDynamics Inc.: Overall Product Portfolio
  • Figure 12.67: SWOT Analysis: Sramek BioDynamics Inc.
  • Figure 12.68: Uscom Ltd: Overall Product Portfolio
  • Figure 12.69: Uscom Ltd.: Overall Financials, 2018-2020
  • Figure 12.70: Uscom Ltd Revenue (by Product), 2018-2020
  • Figure 12.71: Uscom Ltd Revenue (by Region), 2018-2020
  • Figure 12.72: Uscom Ltd R&D Expenditure 2018-2020
  • Figure 12.73: SWOT Analysis: Uscom Ltd
目次
Product Code: BHM1046SA

Global Hemodynamic Monitoring Devices Market to Reach $2,156.6 Million by 2030

Market Report Coverage - Hemodynamic Monitoring Devices

Market Segmentation

  • Product (Catheters, Sensors, Monitoring System, and Others)
  • Modality (Invasive, Minimally Invasive, Non-Invasive)
  • Setting (Hospitals, Clinics, Ambulatory Units, Homecare, and Others)

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe)
  • Asia-Pacific (Japan, China, South Korea, Australia, and New Zealand, India, Singapore, and Rest-of-Asia-Pacific)
  • Latin America (Brazil, Mexico, Argentina, Colombia, and Rest-of-Latin America)
  • Middle East and Africa (K.S.A., Israel, South Africa, and Rest-of-MEA)

Growth Drivers

  • Rising Prevalence of Cardiac Disorders
  • Increasing Technology Integration in Hemodynamic Monitoring
  • Development of Remote Hemodynamic Monitoring Devices
  • Entry of Key Medical Device Companies Through Mergers and Acquisitions

Market Challenges

  • Lack of Clinically Validated Evidence for Non-Invasive Hemodynamic Monitoring
  • Side-Effects Associated with Invasive Hemodynamic Monitoring

Market Opportunities

  • Emergence of Regional Hemodynamic Monitoring Devices Companies
  • Development of Patient-Friendly Hemodynamic Monitoring Systems
  • Development of Virtual Training Applications for Medical Staff

Key Companies Profiled

Baxter International Inc, Caretaker, LLC, CN Systems Medizintechnik GmbH, Deltex Medical Group PLC, Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, GENERAL ELECTRIC COMPANY, Getinge AB, ICU MEDICAL, INC., Koninklijke Philips N.V., Masimo Corporation, Schwarzer Cardiotek, Sramek BioDynamics Inc., and Uscom Ltd

Key Questions Answered in this Report:

  • What has been the impact of COVID-19 on the global hemodynamic monitoring devices market?
  • What is the anticipated impact of COVID-19 on the global market in mid-term and long-term duration?
  • What are the key technological trends that influence the global hemodynamic monitoring devices market? What is their future potential?
  • Who are the emerging players in the global hemodynamic monitoring devices market that have received funding?
  • What are the regulations for hemodynamic monitoring devices across various regions?
  • How has the patent filing trend influenced the growth of the global hemodynamic monitoring devices market?
  • Who are the key players in the global hemodynamic monitoring devices market?
  • What are the key synergistic activities employed by the companies operating or entering in global hemodynamic monitoring devices market?
  • What are the key drivers and restraints for the global hemodynamic monitoring devices market?
  • What are the growth opportunities in the global hemodynamic monitoring devices market? What is the potential of such opportunities in mid-term and long-term duration?
  • Which product type is anticipated to grow with the highest CAGR during the forecast period 2021-2030?
  • What is the anticipated growth trajectory of minimally invasive and non-invasive modalities of hemodynamic monitoring during the forecast period 2021-2030?
  • Which region is anticipated to dominate the global hemodynamic monitoring devices market during the forecast period 2021-2030?
  • What is the anticipated growth potential of various end users and modalities in emerging economies such as Asia-Pacific, Latin America, and the Middle East, and Africa?

Key USPs of the Report

Following are some of the key contents of the report:

  • Funding Scenario

This section encompasses a description of the current funding landscape in the global hemodynamic monitoring devices market for emerging companies

  • Key Technology Trends

This section is intended to aid the readers in identifying the key technological trends and their futuristic growth potential in short-, mid, and long-term duration in the global hemodynamic monitoring devices market.

  • Business Model Analysis

This section comprises information on the key business models deployed in the market by leading players.

  • Impact of COVID-19

This section of the report encompasses the following:

    • Impact on Facilities
    • Impact on Remote Monitoring
    • Impact on Market Size

In addition, the report provides:

  • A detailed analysis and growth forecast (2021-2030) for different market segments
  • Recent developments and trends in the global market landscape
  • Factors promoting and inhibiting the market growth

Scope of the Global Hemodynamic Monitoring Devices Market

The purpose of the study is to enable the reader to gain a holistic view of the global hemodynamic monitoring devices by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global hemodynamic monitoring devices market, including a thorough analysis of the products, modality, setting, and regional segmentation. The study also provides market and business-related information on various segments.

Key Companies in Hemodynamic Monitoring Devices Market

Some of the key players contributing to the global hemodynamic monitoring devices market include Baxter International Inc, Caretaker, LLC, CN Systems Medizintechnik GmbH, Deltex Medical Group PLC, Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, GENERAL ELECTRIC COMPANY, Getinge AB, ICU MEDICAL, INC., Koninklijke Philips N.V., Masimo Corporation, Schwarzer Cardiotek, Sramek BioDynamics Inc., and Uscom Ltd.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of Research

  • 2.1 Scope of Study
  • 2.2 Inclusion and Exclusion Criteria
  • 2.3 Key Questions to be Answered in the Report

3 Research Methodology

  • 3.1 Data Collection and Analysis
  • 3.2 Data Sources
    • 3.2.1 Primary Data Sources
    • 3.2.2 Secondary Data Sources
  • 3.3 Data Triangulation
  • 3.4 Market Estimation
  • 3.5 Forecast Period Selection Criteria
  • 3.6 Assumptions and Limitations

4 Impact of COVID-19 on Hemodynamic Monitoring Devices

  • 4.1 Impact on Facilities
  • 4.2 Impact on Remote Monitoring
  • 4.3 Impact on Market Size
    • 4.3.1 Scenario Comparative Analysis (Pre-COVID, During- COVID, Post-COVID)
    • 4.3.2 Quarterly Regional Impact
    • 4.3.3 Impact Due to COVID-19
      • 4.3.3.1 Short-Term
      • 4.3.3.2 Mid-Term
      • 4.3.3.3 Long-Term
  • 4.4 Future Outlook and Recommendations

5 Industry Analysis

  • 5.1 Disease Epidemiology Analysis and Forecast (2000-2030)
    • 5.1.1 Cardiovascular Diseases
    • 5.1.2 Diabetes
  • 5.2 Technology Landscape
    • 5.2.1 Key Trends
      • 5.2.1.1 Short-Term Potential (2-4 Years)
      • 5.2.1.2 Mid-Term Potential (5-10 Years)
      • 5.2.1.3 Long-Term Potential (8-12 Years)
  • 5.3 Value Chain Analysis
  • 5.4 End User Perceptions
  • 5.5 Funding Scenario
  • 5.6 Regulatory Framework and Government Initiatives
    • 5.6.1 North America
      • 5.6.1.1 Food and Drug Administration (FDA)
      • 5.6.1.2 Health Canada
    • 5.6.2 Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 Japan
      • 5.6.3.2 China
    • 5.6.4 Latin America
      • 5.6.4.1 Brazil
      • 5.6.4.2 Mexico
  • 5.7 Patent Analysis
    • 5.7.1 Awaited Technological Developments
    • 5.7.2 Patent Filing Trend
  • 5.8 Product Benchmarking
  • 5.9 Ongoing Clinical Trials

6 Competitive Landscape

  • 6.1 Market Share Analysis
  • 6.2 Key Strategies and Developments
    • 6.2.1 Regulatory and Legal
    • 6.2.2 Funding Activities
    • 6.2.3 Mergers & Acquisition Activities
    • 6.2.4 Partnerships, Collaborations, and Business Expansions
    • 6.2.5 New Offerings
  • 6.3 Business Model Analysis
  • 6.4 Key Players-Competitive Benchmarking

7 Global Hemodynamic Monitoring Devices Market Scenario

  • 7.1 Assumptions and Limitations
  • 7.2 Key Findings and Opportunity Assessment
  • 7.3 Global Hemodynamic Monitoring Devices Market Size and Forecast
    • 7.3.1 Realistic Growth Scenario
    • 7.3.2 Pessimistic/Conservative Growth Scenario
    • 7.3.3 Optimistic Growth Scenario
  • 7.4 Market Dynamics
    • 7.4.1 Impact Analysis
    • 7.4.2 Market Growth Promoting Factors
      • 7.4.2.1 Rising Prevalence of Cardiac Disorders
      • 7.4.2.2 Increasing Technology Integration in Hemodynamic Monitoring
      • 7.4.2.3 Development of Remote Hemodynamic Monitoring Devices
      • 7.4.2.4 Entry of Key Medical Device Companies Through Mergers and Acquisitions
    • 7.4.3 Market Growth Restraining Factors
      • 7.4.3.1 Lack of Clinically Validated Evidence for Non-Invasive Hemodynamic Monitoring
      • 7.4.3.2 Side-Effects Associated with Invasive Hemodynamic Monitoring
    • 7.4.4 Market Growth Opportunities
      • 7.4.4.1 The Emergence of Regional Hemodynamic Monitoring Devices Companies
      • 7.4.4.2 Development of Patient-Friendly Hemodynamic Monitoring Systems
      • 7.4.4.3 Development of Virtual Training Applications for Medical Staff
      • 7.4.4.4 Opportunities Potential
        • 7.4.4.4.1 Short-Term
        • 7.4.4.4.2 Mid-Term
        • 7.4.4.4.3 Long-Term

8 Global Hemodynamic Monitoring Devices Market (by Product)

  • 8.1 Opportunity Assessment
  • 8.2 Catheters
  • 8.3 Sensors
  • 8.4 Monitoring System
  • 8.5 Others (Probes, Pods, etc.)

9 Global Hemodynamic Monitoring Devices Market (by Modality)

  • 9.1 Opportunity Assessment
  • 9.2 Invasive
  • 9.3 Minimally Invasive
  • 9.4 Non-Invasive

10 Global Hemodynamic Monitoring Devices Market (by Setting)

  • 10.1 Opportunity Assessment
  • 10.2 Hospitals
  • 10.3 Clinics
  • 10.4 Ambulatory Units
  • 10.5 Homecare
  • 10.6 Others (Nursing Home, Elderly Care Homes, etc.)

11 Global Hemodynamic Monitoring Devices Market (by Geography)

  • 11.1 Overview
  • 11.2 North America Hemodynamic Monitoring Devices Market
    • 11.2.1 Key Findings and Opportunity Assessment
    • 11.2.2 Market Dynamics: Impact Analysis
    • 11.2.3 Market Size and Forecast
      • 11.2.3.1 By Product
      • 11.2.3.2 By Modality
      • 11.2.3.3 By Setting
      • 11.2.3.4 By Country
        • 11.2.3.4.1 U.S.
        • 11.2.3.4.2 Canada
  • 11.3 Europe Hemodynamic Monitoring Devices Market
    • 11.3.1 Key Findings and Opportunity Assessment
    • 11.3.2 Market Dynamics: Impact Analysis
    • 11.3.3 Market Size and Forecast
      • 11.3.3.1 By Product
      • 11.3.3.2 By Modality
      • 11.3.3.3 By Setting
      • 11.3.3.4 By Country
        • 11.3.3.4.1 Germany
        • 11.3.3.4.2 U.K.
        • 11.3.3.4.3 France
        • 11.3.3.4.4 Italy
        • 11.3.3.4.5 Spain
        • 11.3.3.4.6 Nordic Countries
        • 11.3.3.4.7 Rest-of-Europe
  • 11.4 Asia-Pacific Hemodynamic Monitoring Devices Market
    • 11.4.1 Key Findings and Opportunity Assessment
    • 11.4.2 Market Dynamics: Impact Analysis
    • 11.4.3 Market Size and Forecast
      • 11.4.3.1 By Product
      • 11.4.3.2 By Modality
      • 11.4.3.3 By Setting
      • 11.4.3.4 By Country
        • 11.4.3.4.1 Japan
        • 11.4.3.4.2 China
        • 11.4.3.4.3 South Korea
        • 11.4.3.4.4 Australia and New Zealand
        • 11.4.3.4.5 India
        • 11.4.3.4.6 Singapore
        • 11.4.3.4.7 Rest-of-Asia-Pacific
  • 11.5 Latin America Hemodynamic Monitoring Devices Market
    • 11.5.1 Key Findings and Opportunity Assessment
    • 11.5.2 Market Dynamics: Impact Analysis
    • 11.5.3 Market Size and Forecast
      • 11.5.3.1 By Product
      • 11.5.3.2 By Modality
      • 11.5.3.3 By Setting
      • 11.5.3.4 By Country
        • 11.5.3.4.1 Brazil
        • 11.5.3.4.2 Mexico
        • 11.5.3.4.3 Argentina
        • 11.5.3.4.4 Colombia
        • 11.5.3.4.5 Rest-of-Latin America
  • 11.6 Middle East and Africa Hemodynamic Monitoring Devices Market
    • 11.6.1 Key Findings and Opportunity Assessment
    • 11.6.2 Market Dynamics: Impact Analysis
    • 11.6.3 Market Size and Forecast
      • 11.6.3.1 By Product
      • 11.6.3.2 By Modality
      • 11.6.3.3 By Setting
      • 11.6.3.4 By Country
        • 11.6.3.4.1 K.S.A.
        • 11.6.3.4.2 Israel
        • 11.6.3.4.3 South Africa
        • 11.6.3.4.4 Rest-of-MEA

12 Company Profiles

  • 12.1 Overview
  • 12.2 Established Companies
    • 12.2.1 Baxter International Inc.
      • 12.2.1.1 Company Overview
      • 12.2.1.2 Role of Baxter International Inc. in Global Hemodynamic Monitoring Devices Market
      • 12.2.1.3 Key Financials
      • 12.2.1.4 R&D Insights
      • 12.2.1.5 Recent Developments
      • 12.2.1.6 SWOT Analysis
    • 12.2.2 Caretaker, LLC
      • 12.2.2.1 Company Overview
      • 12.2.2.2 Role of Caretaker, LLC in Global Hemodynamic Monitoring Devices Market
      • 12.2.2.3 Recent Developments
      • 12.2.2.4 SWOT Analysis
    • 12.2.3 CN Systems Medizintechnik GmbH
      • 12.2.3.1 Company Overview
      • 12.2.3.2 Role of CN Systems Medizintechnik GmbH in Global Hemodynamic Monitoring Devices Market
      • 12.2.3.3 Recent Developments
      • 12.2.3.4 SWOT Analysis
    • 12.2.4 Deltex Medical Group PLC
      • 12.2.4.1 Company Overview
      • 12.2.4.2 Role of Deltex Medical Group PLC in Global Hemodynamic Monitoring Devices Market
      • 12.2.4.3 Key Financials
      • 12.2.4.4 R&D Insights
      • 12.2.4.5 Recent Developments
      • 12.2.4.6 SWOT Analysis
    • 12.2.5 Dragerwerk AG & Co. KGaA
      • 12.2.5.1 Company Overview
      • 12.2.5.2 Role of Dragerwerk AG & Co. KGaA in Global Hemodynamic Monitoring Devices Market
      • 12.2.5.3 Key Financials
      • 12.2.5.4 R&D Insights
      • 12.2.5.5 Recent Developments
      • 12.2.5.6 SWOT Analysis
    • 12.2.6 Edwards Lifesciences Corporation.
      • 12.2.6.1 Company Overview
      • 12.2.6.2 Role of Edwards Lifesciences Corporation. in Global Hemodynamic Monitoring Devices Market
      • 12.2.6.3 Key Financials
      • 12.2.6.4 R&D Insights
      • 12.2.6.5 Recent Developments
      • 12.2.6.6 SWOT Analysis
    • 12.2.7 GENERAL ELECTRIC COMPANY
      • 12.2.7.1 Company Overview
      • 12.2.7.2 Role of GENERAL ELECTRIC COMPANY in Global Hemodynamic Monitoring Devices Market
      • 12.2.7.3 Key Financials
      • 12.2.7.4 R&D Insights
      • 12.2.7.5 Recent Developments
      • 12.2.7.6 SWOT Analysis
    • 12.2.8 Getinge AB
      • 12.2.8.1 Company Overview
      • 12.2.8.2 Role of Getinge AB in Global Hemodynamic Monitoring Devices Market
      • 12.2.8.3 Key Financials
      • 12.2.8.4 R&D Insights
      • 12.2.8.5 Recent Developments
      • 12.2.8.6 SWOT Analysis
    • 12.2.9 ICU MEDICAL, INC.
      • 12.2.9.1 Company Overview
      • 12.2.9.2 Role of ICU MEDICAL, INC. in Global Hemodynamic Monitoring Devices Market
      • 12.2.9.3 Key Financials
      • 12.2.9.4 R&D Insights
      • 12.2.9.5 Recent Developments
      • 12.2.9.6 SWOT Analysis
    • 12.2.10 Koninklijke Philips N.V.
      • 12.2.10.1 Company Overview
      • 12.2.10.2 Role of Koninklijke Philips N.V. in Global Hemodynamic Monitoring Devices Market
      • 12.2.10.3 Key Financials
      • 12.2.10.4 R&D Insights
      • 12.2.10.5 Recent Developments
      • 12.2.10.6 SWOT Analysis
    • 12.2.11 Masimo Corporation (Parent Company of LiDCO Group PLC)
      • 12.2.11.1 Company Overview
      • 12.2.11.2 Role of Masimo Corporation in Global Hemodynamic Monitoring Devices Market
      • 12.2.11.3 Key Financials
      • 12.2.11.4 R&D Insights
      • 12.2.11.5 Recent Developments
      • 12.2.11.6 SWOT Analysis
    • 12.2.12 NI Medical Ltd.
      • 12.2.12.1 Company Overview
      • 12.2.12.2 Role of NI Medical Ltd. in Global Hemodynamic Monitoring Devices Market
      • 12.2.12.3 Recent Developments
      • 12.2.12.4 SWOT Analysis
    • 12.2.13 Osypka Medical GmbH
      • 12.2.13.1 Company Overview
      • 12.2.13.2 Role of Osypka Medical GmbH in Global Hemodynamic Monitoring Devices Market
      • 12.2.13.3 Recent Developments
      • 12.2.13.4 SWOT Analysis
    • 12.2.14 Schwarzer Cardiotek
      • 12.2.14.1 Company Overview
      • 12.2.14.2 Role of Schwarzer Cardiotek in Global Hemodynamic Monitoring Devices Market
      • 12.2.14.3 Recent Developments
      • 12.2.14.4 SWOT Analysis
    • 12.2.15 Sramek BioDynamics Inc. (Formally Known as Hemo Sapiens Inc.)
      • 12.2.15.1 Company Overview
      • 12.2.15.2 Role of Sramek BioDynamics Inc. in Global Hemodynamic Monitoring Devices Market
      • 12.2.15.3 Recent Developments
      • 12.2.15.4 SWOT Analysis
    • 12.2.16 Uscom Ltd
      • 12.2.16.1 Company Overview
      • 12.2.16.2 Role of Uscom Ltd in Global Hemodynamic Monitoring Devices Market
      • 12.2.16.3 Key Financials
      • 12.2.16.4 R&D Insights
      • 12.2.16.5 Recent Developments
      • 12.2.16.6 SWOT Analysis
  • 12.3 Snapshots of Emerging Companies
    • 12.3.1 Flosonics Medical
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Role of Flosonics Medical in Global Hemodynamic Monitoring Devices Market
      • 12.3.1.3 Recent Developments
    • 12.3.2 Heart Kinetics
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Role of Heart Kinetics in Global Hemodynamic Monitoring Devices Market
    • 12.3.3 Retia Medical
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Role of Retia Medical in Global Hemodynamic Monitoring Devices Market
      • 12.3.3.3 Recent Developments